Genentech Launches Employee Retention Program
Tacked on to Genentech's press statement about its rejection of Roche's offer, the biotech firm announced the formation of a program to address employee concerns.
Preemption Makes Waves in Two More Cases
The case for preemption gets shot down in Texas, but holds up in yet another Medtronic suit in Minnesota.
Merck Vaccine Market Takes Center Stage
Margaret McGlynn, Merck's head of vaccines, expounded yesterday on the state of the company's vaccine program, including campaign strategies, product development, and a new reimbursement program for doctors.
